Elevated procaspase levels in human melanoma

Melanoma Research

Volumn 11, Issue 4, 2001, Pages 385-393

  Fink, D ^a   Schlagbauer Wadl, H ^a   Selzer, E ^b   Lucas, T ^a   Wolff, K ^a   Pehamberger, H ^a   Eichler, H G ^a   Jansen, B ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; Caspase; Melanocyte; Melanoma; Transformation

Indexed keywords

CASPASE; PROCASPASE 3; PROCASPASE 7; PROCASPASE 8; UNCLASSIFIED DRUG;

ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, WESTERN; CASPASES; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; ENZYME INDUCTION; ENZYME PRECURSORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOCYTES; MELANOMA; MOLECULAR WEIGHT; TUMOR CELLS, CULTURED;

EID: 0034907839     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200108000-00009     Document Type: Article

References (50)

1. Molecular genetics of human malignant melanoma
2. Heterogeneity of chemosensitivity of metastatic cutaneous melanoma
3. Caspases: Killer proteases
4. Role of proteases in activation of apoptosis
5. Apoptotic pathways: The roads to ruin
6. The molecular mechanism of programmed cell death in C. elegans
7. Dysregulation of apoptosis in cancer
8. The molecular biology of apoptosis
9. Identification of a new caspase homologue: Caspase-14
10. Signal transduction mediated by Bid, a pro-death Bcl-2 family protein, connects the death receptor and mitochondria apoptosis pathways
11. Executioner caspases-3, -6 and -7 perform distinct, non-redundant, roles during the demolition phase of apoptosis
12. RAIDD is a new 'death' adaptor molecule
13. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment
14. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes
15. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3
16. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE
17. Differential requirement for caspase 9 in apoptotic pathways in vivo
18. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
19. The CARD domain: A new apoptotic signalling motif
20. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death
21. RIP and FADD: Two 'death domain'-containing proteins can induce apoptosis by convergent, but dissociable, pathways
22. Activation of the c-Jun N-terminal kinase/stress-activated protein kinase pathway by overexpression of caspase-8 and its homologs
23. Fas- and TNT-mediated apoptosis use the same binding surface of FADD to trigger a signal transduction: A typical model for a convergent signal transduction
24. The three-dimensional solution structure and dynamic properties of the human FADD death domain
25. Fas-induced DNA fragmentation and proteolysis of nuclear proteins
26. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis
27. Evidence for a p23 caspase-cleaved form of p27[KIP1] involved in G1 growth arrest
28. Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis
29. Involvement of caspase 3-activated DNase in internucleosomal DNA cleavage induced by diverse apoptotic stimuli
30. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
31. Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines
32. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells
33. Interleukin 1beta-converting enzyme (caspase-1) is overexpressed in adenocarcinoma of the pancreas
34. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions
35. The prodomain of caspase-1 enhances fas-mediated apoptosis through facilitation of caspase-8 activation
36. Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release
37. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
38. The chemoresistance of human malignant melanoma: An update
39. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis
40. Two CD95 (APO-1/Fas) signaling pathways
41. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
42. Caspase-independent cell killing by Fas-associated protein with death domain
43. FADD is required for multiple signaling events downstream of the receptor Fas
44. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death
45. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
46. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
47. Inhibition of death receptor signals by cellular FLIP
48. Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells
49. STAT-1-independent upregulation of FADD and procaspase-3 and -8 in cancer cells treated with cytotoxic drugs
50. Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice